SHEILA ANNE BOBIS: Open Payments
NPI 1083024699 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,076 in 119 payments from 10 companies in 2025. Trend: 2023 $5,099 · 2024 $5,128 · 2025 $9,076
Speaker / faculty: $5,629Food & beverage: $2,624Travel & lodging: $745Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $5,241 |
| PFIZER INC. | 39 | $2,601 |
| Axsome Therapeutics, Inc. | 12 | $619 |
| Lundbeck LLC | 11 | $169 |
| Teva Pharmaceuticals USA, Inc. | 7 | $138 |
| SCILEX PHARMACEUTICALS INC. | 2 | $91 |
| ARGENX US, INC. | 5 | $82 |
| Lilly USA, LLC | 4 | $80 |
| UCB, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
Products named: QULIPTA, NURTEC ODT, UBRELVY, Symbravo, VYEPTI, AUSTEDO XR, ZTLido, VYVGART HYTRULO.
Industry payments across CA — which companies pay providers there.
